Copyright Reports & Markets. All rights reserved.

Global Cell and Gene Therapy Drug Delivery Devices Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Sterile Insulin Syringe
    • 1.2.3 Pre-Filled Syringe
    • 1.2.4 Infusion Bags
  • 1.3 Market by Application
    • 1.3.1 Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Luxturna
    • 1.3.3 Kymriah
    • 1.3.4 Provenge
    • 1.3.5 Zolgensma
    • 1.3.6 Yescarta
    • 1.3.7 Strimvelis
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Perspective (2016-2027)
  • 2.2 Cell and Gene Therapy Drug Delivery Devices Growth Trends by Regions
    • 2.2.1 Cell and Gene Therapy Drug Delivery Devices Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Cell and Gene Therapy Drug Delivery Devices Historic Market Share by Regions (2016-2021)
    • 2.2.3 Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Regions (2022-2027)
  • 2.3 Cell and Gene Therapy Drug Delivery Devices Industry Dynamic
    • 2.3.1 Cell and Gene Therapy Drug Delivery Devices Market Trends
    • 2.3.2 Cell and Gene Therapy Drug Delivery Devices Market Drivers
    • 2.3.3 Cell and Gene Therapy Drug Delivery Devices Market Challenges
    • 2.3.4 Cell and Gene Therapy Drug Delivery Devices Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue
    • 3.1.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue (2016-2021)
    • 3.1.2 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Players (2016-2021)
  • 3.2 Global Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Cell and Gene Therapy Drug Delivery Devices Revenue
  • 3.4 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio
    • 3.4.1 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Drug Delivery Devices Revenue in 2020
  • 3.5 Cell and Gene Therapy Drug Delivery Devices Key Players Head office and Area Served
  • 3.6 Key Players Cell and Gene Therapy Drug Delivery Devices Product Solution and Service
  • 3.7 Date of Enter into Cell and Gene Therapy Drug Delivery Devices Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Type

  • 4.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Type (2016-2021)
  • 4.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2022-2027)

5 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Application

  • 5.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Application (2016-2021)
  • 5.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size (2016-2027)
  • 6.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type
    • 6.2.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021)
    • 6.2.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027)
    • 6.2.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2027)
  • 6.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application
    • 6.3.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021)
    • 6.3.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027)
    • 6.3.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2027)
  • 6.4 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
    • 6.4.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021)
    • 6.4.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size (2016-2027)
  • 7.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type
    • 7.2.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021)
    • 7.2.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027)
    • 7.2.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2027)
  • 7.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application
    • 7.3.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021)
    • 7.3.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027)
    • 7.3.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2027)
  • 7.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country
    • 7.4.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021)
    • 7.4.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size (2016-2027)
  • 8.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type
    • 8.2.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application
    • 8.3.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region
    • 8.4.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size (2016-2027)
  • 9.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type
    • 9.2.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021)
    • 9.2.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027)
    • 9.2.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2027)
  • 9.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application
    • 9.3.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021)
    • 9.3.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027)
    • 9.3.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2027)
  • 9.4 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
    • 9.4.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021)
    • 9.4.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size (2016-2027)
  • 10.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type
    • 10.2.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application
    • 10.3.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country
    • 10.4.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Amgen, Inc.
    • 11.1.1 Amgen, Inc. Company Details
    • 11.1.2 Amgen, Inc. Business Overview
    • 11.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.1.4 Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.1.5 Amgen, Inc. Recent Development
  • 11.2 Bausch and Lomb Incorporated
    • 11.2.1 Bausch and Lomb Incorporated Company Details
    • 11.2.2 Bausch and Lomb Incorporated Business Overview
    • 11.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.2.4 Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.2.5 Bausch and Lomb Incorporated Recent Development
  • 11.3 Becton, Dickinson and Company
    • 11.3.1 Becton, Dickinson and Company Company Details
    • 11.3.2 Becton, Dickinson and Company Business Overview
    • 11.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.3.4 Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.3.5 Becton, Dickinson and Company Recent Development
  • 11.4 Bluebird bio, Inc.
    • 11.4.1 Bluebird bio, Inc. Company Details
    • 11.4.2 Bluebird bio, Inc. Business Overview
    • 11.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.4.4 Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.4.5 Bluebird bio, Inc. Recent Development
  • 11.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
    • 11.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Details
    • 11.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
    • 11.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Development
  • 11.6 Dendreon Pharmaceuticals LLC.
    • 11.6.1 Dendreon Pharmaceuticals LLC. Company Details
    • 11.6.2 Dendreon Pharmaceuticals LLC. Business Overview
    • 11.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.6.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.6.5 Dendreon Pharmaceuticals LLC. Recent Development
  • 11.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
    • 11.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Company Details
    • 11.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
    • 11.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Development
  • 11.8 Human Stem Cell Institute
    • 11.8.1 Human Stem Cell Institute Company Details
    • 11.8.2 Human Stem Cell Institute Business Overview
    • 11.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.8.4 Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.8.5 Human Stem Cell Institute Recent Development
  • 11.9 Kite Pharma, Inc.
    • 11.9.1 Kite Pharma, Inc. Company Details
    • 11.9.2 Kite Pharma, Inc. Business Overview
    • 11.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.9.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.9.5 Kite Pharma, Inc. Recent Development
  • 11.10 Kolon Tissue Gene, inc.
    • 11.10.1 Kolon Tissue Gene, inc. Company Details
    • 11.10.2 Kolon Tissue Gene, inc. Business Overview
    • 11.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.10.4 Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.10.5 Kolon Tissue Gene, inc. Recent Development
  • 11.11 Novartis AG
    • 11.11.1 Novartis AG Company Details
    • 11.11.2 Novartis AG Business Overview
    • 11.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.11.4 Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.11.5 Novartis AG Recent Development
  • 11.12 Orchard Therapeutics plc.
    • 11.12.1 Orchard Therapeutics plc. Company Details
    • 11.12.2 Orchard Therapeutics plc. Business Overview
    • 11.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.12.4 Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.12.5 Orchard Therapeutics plc. Recent Development
  • 11.13 Pfizer, Inc.
    • 11.13.1 Pfizer, Inc. Company Details
    • 11.13.2 Pfizer, Inc. Business Overview
    • 11.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.13.4 Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.13.5 Pfizer, Inc. Recent Development
  • 11.14 Renova Therapeutics
    • 11.14.1 Renova Therapeutics Company Details
    • 11.14.2 Renova Therapeutics Business Overview
    • 11.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.14.4 Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.14.5 Renova Therapeutics Recent Development
  • 11.15 Spark Therapeutics, Inc.
    • 11.15.1 Spark Therapeutics, Inc. Company Details
    • 11.15.2 Spark Therapeutics, Inc. Business Overview
    • 11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.15.4 Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.15.5 Spark Therapeutics, Inc. Recent Development
  • 11.16 uniQure N.V.
    • 11.16.1 uniQure N.V. Company Details
    • 11.16.2 uniQure N.V. Business Overview
    • 11.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.16.4 uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.16.5 uniQure N.V. Recent Development
  • 11.17 Vericel Corporation
    • 11.17.1 Vericel Corporation Company Details
    • 11.17.2 Vericel Corporation Business Overview
    • 11.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.17.4 Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
    • 11.17.5 Vericel Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Cell and Gene Therapy Drug Delivery Devices Scope and Market Size
    Cell and Gene Therapy Drug Delivery Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell and Gene Therapy Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Sterile Insulin Syringe
    Pre-Filled Syringe
    Infusion Bags

    Segment by Application
    Luxturna
    Kymriah
    Provenge
    Zolgensma
    Yescarta
    Strimvelis

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Amgen, Inc.
    Bausch and Lomb Incorporated
    Becton, Dickinson and Company
    Bluebird bio, Inc.
    Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
    Dendreon Pharmaceuticals LLC.
    Helixmith Co., Ltd (ViroMed Co., Ltd)
    Human Stem Cell Institute
    Kite Pharma, Inc.
    Kolon Tissue Gene, inc.
    Novartis AG
    Orchard Therapeutics plc.
    Pfizer, Inc.
    Renova Therapeutics
    Spark Therapeutics, Inc.
    uniQure N.V.
    Vericel Corporation

    Buy now